Li et al., 2019
- ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.
Nature medicine
25(7):1116-1122
Full text @ Nat. Med.
Name |
---|
EGFP |
mCherry |